Resonance Health Limited (ASX:RHT)
Australia · Delayed Price · Currency is AUD 0.0590
-0.0030 (-4.84%)
Sep 9, 2026, 3:39 PM AEST
Resonance Health Financials Overview
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Revenue Revenue Growth | 15.75 | 15.75 | 11.07 | 8.59 | 4.4 | 3.85 |
Revenue Growth | 13.83% | 42.25% | 28.91% | 95.02% | 14.31% | 1.96% |
Gross Profit Gross Profit Growth | 15.21 | 15.21 | 10.71 | 8.59 | 4.4 | 3.85 |
Operating Income Operating Income Growth | 1.84 | 1.84 | -1.54 | -0.53 | -1.36 | -1.52 |
Net Income Net Income Growth | 1.51 | 1.51 | -1.73 | 0.17 | -0.78 | -1.14 |
Earnings Per Share EPS Growth | 0.00 | 0.00 | -0.00 | 0.00 | -0.00 | -0.00 |
EPS Growth | 90.53% | - | - | - | - | - |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 |
|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 |
Intersegment Elimination Intersegment Elimination Growth | -2.97 | -2.97 | -1.01 | -0.23 |
Resonance Clinical Resonance Clinical Growth | 7.54 | 7.54 | 4.16 | 3.93 |
Trialswest Trialswest Growth | 4.15 | 4.15 | 2.66 | 0.35 |
SaMD (Including Research & Development ) SaMD (Including Research & Development ) Growth | 7.04 | 7.04 | 5.27 | - |
Total Total Growth | 15.75 | 15.75 | 11.07 | 8.59 |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Cash & Investments Cash & Investments Growth | 4.85 | 4.85 | 2.98 | 6.85 | 6.36 | 6.78 |
Total Debt Total Debt Growth | 3.81 | 3.81 | 3.8 | 3.7 | 0.27 | 0.27 |
Net Cash (Debt) Net Cash Growth | 1.04 | 1.04 | -0.83 | 3.16 | 6.09 | 6.51 |
Net Cash Growth | - | - | - | -48.13% | -6.54% | -25.94% |
Net Cash Per Share Net Cash Per Share Growth | 0.00 | 0.00 | -0.00 | 0.01 | 0.01 | 0.01 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 2.88 | 2.88 | 1.25 | 1.39 | -0.16 | -1.46 |
Capital Expenditures CapEx Growth | -0.09 | -0.09 | -0.44 | -0.23 | -0.29 | -0.12 |
Free Cash Flow Free Cash Flow Growth | 2.79 | 2.79 | 0.81 | 1.16 | -0.45 | -1.57 |
Free Cash Flow Growth | 5840.64% | 245.98% | -30.45% | - | - | - |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Gross Margin | 96.58% | 96.58% | 96.74% | 100.00% | 100.00% | 100.00% |
Operating Margin | 11.69% | 11.69% | -13.95% | -6.16% | -30.89% | -39.57% |
Pretax Margin | 6.98% | 6.98% | -19.86% | -7.30% | -28.70% | -40.27% |
Profit Margin | 9.61% | 9.61% | -15.65% | 1.97% | -17.72% | -29.63% |
FCF Margin | 17.69% | 17.69% | 7.27% | 13.48% | -10.11% | -40.86% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 9, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
PE Ratio | 20.00 | 13.87 | - | 155.74 | - | - |
P/FCF Ratio | 10.62 | 7.53 | 22.26 | 22.77 | - | - |
PS Ratio | 1.88 | 1.33 | 1.62 | 3.07 | 4.40 | 6.70 |